Please use this identifier to cite or link to this item: https://doi.org/10.3389/fnins.2017.00073
Title: Membrane active antimicrobial peptides: Translating mechanistic insights to design
Authors: Li, J 
Koh, J.-J
Liu, S 
Lakshminarayanan, R 
Verma, C.S 
Beuerman, R.W 
Keywords: adenosine triphosphate
amino acid
brilacidin
dimethyldioctadecylammonium bromide
exeporfinium chloride
polymyxin B
polypeptide antibiotic agent
porphyrin derivative
transcription factor
unclassified drug
xf 73
antibiotic resistance
bacterial membrane
bactericidal activity
bacteriostasis
biophysics
cell membrane
cross linking
drug mechanism
epithelium cell
Gram negative bacterium
Gram positive bacterium
hydrophobicity
immune response
innate immunity
methicillin resistant Staphylococcus aureus
microbiology
molecular dynamics
nonhuman
propensity score
Review
simulation
Issue Date: 2017
Publisher: Frontiers Media
Citation: Li, J, Koh, J.-J, Liu, S, Lakshminarayanan, R, Verma, C.S, Beuerman, R.W (2017). Membrane active antimicrobial peptides: Translating mechanistic insights to design. Frontiers in Neuroscience 11 (FEB) : 73. ScholarBank@NUS Repository. https://doi.org/10.3389/fnins.2017.00073
Rights: Attribution 4.0 International
Abstract: Antimicrobial peptides (AMPs) are promising next generation antibiotics that hold great potential for combating bacterial resistance. AMPs can be both bacteriostatic and bactericidal, induce rapid killing and display a lower propensity to develop resistance than do conventional antibiotics. Despite significant progress in the past 30 years, no peptide antibiotic has reached the clinic yet. Poor understanding of the action mechanisms and lack of rational design principles have been the two major obstacles that have slowed progress. Technological developments are now enabling multidisciplinary approaches including molecular dynamics simulations combined with biophysics and microbiology toward providing valuable insights into the interactions of AMPs with membranes at atomic level. This has led to increasingly robust models of the mechanisms of action of AMPs and has begun to contribute meaningfully toward the discovery of new AMPs. This review discusses the detailed action mechanisms that have been put forward, with detailed atomistic insights into how the AMPs interact with bacterial membranes. The review further discusses how this knowledge is exploited toward developing design principles for novel AMPs. Finally, the current status, associated challenges, and future directions for the development of AMP therapeutics are discussed. © 2017 Li, Koh, Liu, Lakshminarayanan, Verma and Beuerman.
Source Title: Frontiers in Neuroscience
URI: https://scholarbank.nus.edu.sg/handle/10635/183546
ISSN: 1662-4548
DOI: 10.3389/fnins.2017.00073
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fnins_2017_00073.pdf1.93 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons